You will need to temporarily discontinue GLP-1 medications (such as Ozempic or Trulicity) prior to your procedure
3.Hiperkaliemia Hiperkaliemia jest stanem chorobowym objawiajcym si zbyt wysokim steniem potasu w osoczu, ktre przekracza warto 5,5 mmol/l
1 Introduction The global prevalence of non-alcoholic fatty liver disease (NAFLD) has shown a consistent upward trend in recent decades, with current estimates indicating an overall prevalence of 30.05% ( In a pivotal 2023 consensus statement, international liver associations proposed redefining disease terminology, replacing NAFLD with metabolic dysfunction-associated steatotic liver disease (MASLD) and NASH with metabolic dysfunction-associated steatohepatitis (MASH) ( MASLD pathogenesis involves complex interactions among multiple pathological processes, including excessive fatty acid accumulation, dysregulated inflammatory responses, oxidative stress, and insulin resistance
A practical addition that can be easily integrated into everyday life before or after physical activity
Rapid weight lossa common outcome of GLP-1 therapycan temporarily disrupt periods, though this effect is usually reversible and manageable
You should resolve whether you want to keep using your syringe until it is empty or start using a new syringe for every new injection
